WESTCLIFFE HEALTH INNOVATIONS LIMITEDActive
Key figures
WESTCLIFFE HEALTH INNOVATIONS LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £1,415,075 (52% of the profit for the year).
Filed accounts2023/24–2024/25
| 2023/24 | 2024/25 | |
|---|---|---|
| Profit for the year | 2,076,782 | 2,722,699 |
| Cash at bank and in hand | 438,551 | 1,420,254 |
| Total assets | 5,697,114 | 6,782,825 |
| Total liabilities | 2,401,046 | 2,201,017 |
| Net assets / total equity | 3,163,622 | 4,471,246 |
| Average number of employees | 105 | 1 |
| Average pay (per year) | 33,159 | 4,291,995 |
| Dividends paid | 1,440,000 | 1,415,075 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the company
As described in the company's latest filed accounts.
Summary: WESTCLIFFE HEALTH INNOVATIONS LIMITED
Company
WESTCLIFFE HEALTH INNOVATIONS LIMITED is a private limited company registered with Companies House under company number 09051512. It was incorporated on 22 May 2014. Its status is active. The registered office is in Bradford (BD10). Its nature of business (SIC 2007) is other human health activities (86900).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files full accounts. Profit for the year was £2,722,699. Net assets were £4,471,246, up 41.3% on the previous year. Cash at bank and in hand was £1,420,254. Total assets were £6,782,825 and total liabilities £2,201,017. The company had an average of 1 employee. Figures are available for 2 financial years (2023/24–2024/25).
Control and charges
2 of 2 registered charges are outstanding.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 16 Feb 2027.